Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 6,115 | 3,240 | 1,651 | 3,102 | 7,715 |
| Operating Income | -6,115 | -3,240 | -1,651 | -3,102 | -7,715 |
| Other Income | 121 | 127 | 131 | 115 | 73 |
| Pre-tax Income | -5,995 | -3,113 | -1,521 | -2,987 | -7,642 |
| Net Income Continuous | -5,995 | -3,113 | -1,521 | -2,987 | -7,642 |
| Net Income | $-5,995 | $-3,113 | $-1,521 | $-2,987 | $-7,642 |
| EPS Basic Total Ops | -128.00 | -66.50 | -32.50 | -64.75 | -162.50 |
| EPS Basic Continuous Ops | -127.95 | -66.44 | -32.46 | -63.83 | -163.10 |
| EPS Diluted Total Ops | -128.00 | -66.50 | -32.50 | -64.75 | -162.50 |
| EPS Diluted Continuous Ops | -127.95 | -66.44 | -32.46 | -63.83 | -163.10 |
| EPS Diluted Before Non-Recurring Items | -127.50 | -67.50 | -32.50 | N/A | N/A |
| EBITDA(a) | $-6,115 | $-3,240 | $-1,651 | $-3,102 | $-7,715 |